0

    539680

    GANGAPHARM

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Ganga Pharmaceuticals Limited Share Price Today

    Investment Returns

    Over 1 Month 1.69% Over 3 Months 2.73% Over 6 Months -17.80% Over 1 Year -12.08%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Ganga Pharmaceuticals Limited fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 0.0
    • P/E Ratio (TTM) 0.0
    • Beta 0.0
    • Book Value / share 0.0
    • Return on equity 0.0%
    • EPS (TTM) 0.0
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.0
    info icon alternate text

    Ganga Pharmaceuticals Limited Financials

    Open financial information
    Revenue
    Net income
    Particulars JUN 2024 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.00
    Net Profit 0.00
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.00
    EBITDA 0.00
    Effective Tax Rate (%) 0.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 2.83
    Operating Expense 2.96
    Net Profit 0.10
    Net Profit Margin (%) 3.53
    Earnings Per Share (EPS) 0.17
    EBITDA 0.32
    Effective Tax Rate (%) 23.07
    Particulars MAR 2025 (Values in Cr)
    Revenue 2.64
    Operating Expense 2.98
    Net Profit 0.08
    Net Profit Margin (%) 3.03
    Earnings Per Share (EPS) 0.16
    EBITDA 0.32
    Effective Tax Rate (%) 22.22
    Particulars MAR 2024 (Values in Cr)
    Revenue 2.74
    Operating Expense 2.91
    Net Profit 0.05
    Net Profit Margin (%) 1.82
    Earnings Per Share (EPS) 0.11
    EBITDA 0.29
    Effective Tax Rate (%) 33.33
    Particulars MAR 2023 (Values in Cr)
    Revenue 2.59
    Operating Expense 2.83
    Net Profit 0.04
    Net Profit Margin (%) 1.54
    Earnings Per Share (EPS) 0.10
    EBITDA 0.30
    Effective Tax Rate (%) 20.00
    Particulars MAR 2022 (Values in Cr)
    Revenue 2.49
    Operating Expense 2.69
    Net Profit 0.04
    Net Profit Margin (%) 1.60
    Earnings Per Share (EPS) 0.09
    EBITDA 0.29
    Effective Tax Rate (%) 20.00
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 13.46
    ROE % 1.13
    ROCE % 3.30
    Total Debt to Total Equity 0.20
    EBITDA Margin 12.12
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 13.30
    ROE % 0.80
    ROCE % 3.18
    Total Debt to Total Equity 0.25
    EBITDA Margin 10.58
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 13.42
    ROE % 0.74
    ROCE % 3.28
    Total Debt to Total Equity 0.35
    EBITDA Margin 11.58
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 13.32
    ROE % 0.74
    ROCE % 3.32
    Total Debt to Total Equity 0.34
    EBITDA Margin 12.05
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 13.23
    ROE % 0.37
    ROCE % 3.30
    Total Debt to Total Equity 0.30
    EBITDA Margin 11.81
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.30
    Total Assets 8.97
    Total Liabilities 8.97
    Total Equity 7.13
    Share Outstanding 0
    Price to Book Ratio 0.76
    Return on Assets (%) 0.88
    Return on Capital (%) 0.92
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.02
    Total Assets 8.64
    Total Liabilities 8.64
    Total Equity 7.05
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 0.53
    Return on Capital (%) 0.55
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.02
    Total Assets 7.98
    Total Liabilities 7.98
    Total Equity 5.45
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 0.49
    Return on Capital (%) 0.54
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.02
    Total Assets 7.99
    Total Liabilities 7.99
    Total Equity 5.41
    Share Outstanding 0
    Price to Book Ratio 0.77
    Return on Assets (%) 0.47
    Return on Capital (%) 0.52
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.01
    Total Assets 7.66
    Total Liabilities 7.66
    Total Equity 5.37
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 0.26
    Return on Capital (%) 0.29
    Particulars MAR 2025 (Values in Cr)
    Net Income 0.09
    Cash from Operations -0.56
    Cash from Investing 1.18
    Cash from Financing -0.33
    Net change in Cash 0.27
    Free Cash Flow -0.46
    Particulars MAR 2024 (Values in Cr)
    Net Income 0.06
    Cash from Operations -1.24
    Cash from Investing 0.12
    Cash from Financing 1.13
    Net change in Cash 0.00
    Free Cash Flow -1.22
    Particulars MAR 2023 (Values in Cr)
    Net Income 0.05
    Cash from Operations -0.02
    Cash from Investing 0.49
    Cash from Financing -0.44
    Net change in Cash 0.00
    Free Cash Flow 0.00
    Particulars MAR 2022 (Values in Cr)
    Net Income 0.05
    Cash from Operations -0.19
    Cash from Investing 0.18
    Cash from Financing 0.02
    Net change in Cash 0.00
    Free Cash Flow -0.18
    Particulars MAR 2021 (Values in Cr)
    Net Income 0.03
    Cash from Operations -0.16
    Cash from Investing 0.27
    Cash from Financing -0.09
    Net change in Cash 0.00
    Free Cash Flow -0.14
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 37.26 15.46 1.80 285.54 23.12 38.85
    BLISS GVS PHARMA LTD 465.70 37.50 4.14 4947.78 118.35 552.90
    CIPLA LTD 1469.00 33.16 3.44 118672.48 1165.55 1672.20
    FERMENTA BIOTECH LTD. 511.60 23.93 3.70 1505.69 256.40 518.45
    GLAXOSMITHKLINE PHARMA LT 2657.20 46.78 19.85 45014.57 2088.00 2935.85
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 37.26 26.06 4.80 285.54 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 520.40 23.33 4.06 1504.51 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8296.00 108.42 23.76 20740.00 7630.00 9850.00
    BLISS GVS PHARMA LTD 465.70 50.40 4.28 4947.78 118.35 552.90

    Ganga Pharmaceuticals Limited shareholding pattern

    Holding
    49.08%
    50.91%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    Ganga Pharmaceuticals Limited Technicals Summary

    12.00 0.00 redarrow
    red-green-graph indicator
    0 Bearish
    0 Bullish
    • 5 Days 0.00
    • 26 Days 0.00
    • 10 Days 0.00
    • 50 Days 0.00
    • 12 Days 0.00
    • 100 Days 0.00
    • 20 Days 0.00
    • 200 Days 0.00
    12.00 PIVOT
    First Support 12.00 First Resistance 12.00 Second Support 12.00 Second Resistance 12.00 Third Support 12.00 Third Resistance 12.00
    RSI 58.88 ADX 40.26 MACD 0.00 Williams % R -50.45 Commodity Channel Index (CCI) -18.58
    Date 2026-02-12 Week 8000.00 Same Day 8000.00 Month 12000.00
    1 Year 4.31 3 Year 3.36
    Over 1 Month
    1.69% down
    Over 1 Year
    -12.08% down
    Over 3 Months
    2.73% down
    Over 3 Years
    -2.63% down
    Over 6 Months
    -17.80% down
    Over 5 Years
    14.86% down

    Ganga Pharmaceuticals Limited Corporate Actions

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Ganga Pharmaceuticals Ltd?

    Answer Field

    Ganga Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 12.00 as on Feb 12 2026 12:00 AM.

    What is the Market Cap of Ganga Pharmaceuticals Ltd Share?

    Answer Field

    The market cap of Ganga Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Feb 12 2026 12:00 AM.

    What is the 52 Week High and Low of Ganga Pharmaceuticals Ltd?

    Answer Field

    The 52 Week High and Low of Ganga Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 14.60 and ₹ 9.35.

    What is 1 year return for Ganga Pharmaceuticals Ltd?

    Answer Field

    The 1 year returns on the stock has been -12.08%.

    What is the P/E Ratio of Ganga Pharmaceuticals Ltd Share?

    Answer Field

    As on Feb 12 2026 12:00 AM the price-to-earnings (PE) ratio for Ganga Pharmaceuticals Ltd share is 0.0.

    What is the PB ratio of Ganga Pharmaceuticals Ltd Share?

    Answer Field

    As on Feb 12 2026 12:00 AM, the price-to-book (PB) ratio for Ganga Pharmaceuticals Ltd share is 0.0.

    How to Buy Ganga Pharmaceuticals Ltd Share?

    Answer Field

    You can trade in Ganga Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Ganga Pharmaceuticals Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Ganga Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Ganga Pharmaceuticals Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |